RNA biomarkers in hypertensive disorders of pregnancy: systematic review
The results of the study confirm the potential of utilising genetic markers in clinical practice to improve pregnancy outcomes and reduce risks for both mother and child. The practical value lies in the possibility of developing new screening programmes and therapeutic strategies based on the individual characteristics of patients, contributing to more effective management of hypertensive disorders during pregnancy.
Authors
- Gulfairuz Urazbayeva (ORCID: https://orcid.org/0000-0003-1584-492X)
- Almagul Kurmanova (ORCID: https://orcid.org/0009-0009-7528-3950)
- Damilya Salimbayeva (ORCID: https://orcid.org/0000-0002-7933-3654)
- Makhambet Smailov
- Altynay Nurmakova
Institutions
- Al-Farabi Kazakh National University (KZ)
- Kazakh National Medical University (KZ)
- Global Health Research Center of Central Asia (KZ)
- Institute Of Perinatology Obstetrics And Gynaecology (AM)
Publication Details
- Journal
- Journal of Perinatal Medicine
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1515/jpm-2025-0143
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00